XTX Topco Ltd purchased a new stake in shares of AdaptHealth Corp. (NASDAQ:AHCO - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 43,160 shares of the company's stock, valued at approximately $468,000.
Several other institutional investors and hedge funds have also recently modified their holdings of AHCO. Raymond James Financial Inc. bought a new stake in shares of AdaptHealth during the fourth quarter valued at approximately $197,000. Geode Capital Management LLC raised its stake in shares of AdaptHealth by 0.7% during the fourth quarter. Geode Capital Management LLC now owns 2,467,769 shares of the company's stock valued at $23,499,000 after acquiring an additional 16,596 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of AdaptHealth by 36.1% during the fourth quarter. Wells Fargo & Company MN now owns 54,546 shares of the company's stock valued at $519,000 after acquiring an additional 14,460 shares in the last quarter. Bank of Montreal Can raised its stake in shares of AdaptHealth by 13.1% during the fourth quarter. Bank of Montreal Can now owns 28,558 shares of the company's stock valued at $272,000 after acquiring an additional 3,299 shares in the last quarter. Finally, Invesco Ltd. raised its stake in shares of AdaptHealth by 12.2% during the fourth quarter. Invesco Ltd. now owns 1,433,172 shares of the company's stock valued at $13,644,000 after acquiring an additional 155,838 shares in the last quarter. Institutional investors own 82.67% of the company's stock.
AdaptHealth Stock Up 2.1%
AHCO stock traded up $0.20 during trading on Tuesday, hitting $9.53. 188,406 shares of the company's stock traded hands, compared to its average volume of 1,449,206. The firm has a market capitalization of $1.29 billion, a P/E ratio of 17.65, a PEG ratio of 0.89 and a beta of 1.58. The business has a fifty day simple moving average of $9.10 and a two-hundred day simple moving average of $9.30. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.14. AdaptHealth Corp. has a 1 year low of $7.11 and a 1 year high of $11.70.
Analyst Ratings Changes
Several brokerages recently issued reports on AHCO. Royal Bank Of Canada cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a report on Thursday, May 8th. Truist Financial cut their price objective on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating on the stock in a report on Monday, May 12th. Finally, Wall Street Zen raised shares of AdaptHealth from a "hold" rating to a "buy" rating in a report on Saturday. Six analysts have rated the stock with a buy rating, According to data from MarketBeat.com, AdaptHealth has an average rating of "Buy" and a consensus price target of $13.40.
Check Out Our Latest Stock Report on AdaptHealth
AdaptHealth Company Profile
(
Free Report)
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Read More

Before you consider AdaptHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.
While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.